The National Football League has signed its first-ever pharmaceutical partner in a multi-year deal with Switzerland-based ...
Today, Folia Health and Novartis Pharmaceuticals, Inc. proudly announce their collaboration on an innovative, at-home ...
Novartis has teamed up with the NFL in a multi-year partnership, marking the first such collaboration between the football ...
The NFL have signed its first-ever pharmaceutical partner in a multi-year deal with Novartis to focus on the NFL’s health ...
Novartis, a pharmaceuticals company, and the National Football League have announced an unprecedented partnership that names Novartis as the official first-in-category corporate pharmaceutical partner ...
Swiss pharmaceutical company Novartis has renewed its 15,865-square-foot office at Property & Building Corporation’s 10 ...
While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...
The NFL has inked a multi-year deal with pharmaceutical giant Novartis, marking its first such partnership. This ...
Under the terms of the agreement, Kyorin will receive $55m upfront and will be eligible for milestone payments of up to ...
The third-place slot marked another return to form. Novo Nordisk’s Wegovy reclaimed the seat it held in December, backed by ...
TOKYO -- Swiss pharmaceutical company Novartis has pegged its cancer-targeting radiopharmaceutical business as its next growth pillar, looking to make it "at least a $10 billion business" over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results